Literature DB >> 11342559

Interactions of the rapsyn RING-H2 domain with dystroglycan.

M Bartoli1, M K Ramarao, J B Cohen.   

Abstract

Rapsyn, a peripheral membrane protein of skeletal muscle, is necessary for the formation of the highly organized structure of the vertebrate neuromuscular junction. For mice lacking rapsyn, there is a failure of postsynaptic specialization characterized by an absence of nicotinic acetylcholine receptors (nAChRs) and other integral and peripheral membrane proteins such as beta-dystroglycan and utrophin. Dystroglycan is necessary for the formation of the mature neuromuscular junction and has been shown to interact directly with rapsyn. Previous studies with rapsyn fragments and mutants, expressed in 293T cells along with nAChRs, establish that the rapsyn tetratricopeptide repeat (TPR) domain is involved in self-association and its coiled-coil domain is necessary for nAChR clustering. The function of the rapsyn RING-H2 domain, which is not necessary for rapsyn self-association or nAChR clustering, is unknown. To further characterize these domains, we have used a yeast two-hybrid assay to test for interactions at the plasma membrane between rapsyn domains and a nAChR beta-subunit fragment, the beta-dystroglycan cytoplasmic domain, or rapsyn domains. The rapsyn coiled-coil domain interacts with the nAChR beta-subunit cytoplasmic domain, but not with itself, other rapsyn domains, or beta-dystroglycan. The RING-H2 domain interacts only with the beta-dystroglycan cytoplasmic domain. Furthermore, when expressed in 293T cells, a rapsyn construct containing as few as two TPRs and the RING-H2 domain self-associates and clusters dystroglycan, but not nAChRs. These results emphasize the modular character of the rapsyn structural domains.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342559     DOI: 10.1074/jbc.M103258200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  The role of the cytoskeleton in neuromuscular junction formation.

Authors:  G Clement Dobbins; Bin Zhang; Wen C Xiong; Lin Mei
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  The actin binding domain of ACF7 binds directly to the tetratricopeptide repeat domains of rapsyn.

Authors:  C Antolik; D H Catino; A M O'Neill; W G Resneck; J A Ursitti; R J Bloch
Journal:  Neuroscience       Date:  2007-01-10       Impact factor: 3.590

Review 3.  Receptor-associated proteins and synaptic plasticity.

Authors:  Emile G Bruneau; Jose A Esteban; Mohammed Akaaboune
Journal:  FASEB J       Date:  2008-10-31       Impact factor: 5.191

4.  Structure and superorganization of acetylcholine receptor-rapsyn complexes.

Authors:  Benoît Zuber; Nigel Unwin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-10       Impact factor: 11.205

Review 5.  Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.

Authors:  Michael H Rivner; Mamatha Pasnoor; Mazen M Dimachkie; Richard J Barohn; Lin Mei
Journal:  Neurol Clin       Date:  2018-05       Impact factor: 3.806

Review 6.  Moving forward with the neuromuscular junction.

Authors:  Claire Legay; Lin Mei
Journal:  J Neurochem       Date:  2017-04-27       Impact factor: 5.372

7.  Identification of pathogenic mutations in the human rapsyn gene.

Authors:  Vanessa Dunne; Ricardo A Maselli
Journal:  J Hum Genet       Date:  2003-03-05       Impact factor: 3.172

8.  A role for the juxtamembrane domain of beta-dystroglycan in agrin-induced acetylcholine receptor clustering.

Authors:  Joanna Kahl; James T Campanelli
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

9.  Dystroglycan versatility in cell adhesion: a tale of multiple motifs.

Authors:  Chris J Moore; Steve J Winder
Journal:  Cell Commun Signal       Date:  2010-02-17       Impact factor: 5.712

10.  Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients.

Authors:  M Milone; X M Shen; D Selcen; K Ohno; J Brengman; S T Iannaccone; C M Harper; A G Engel
Journal:  Neurology       Date:  2009-07-21       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.